Capital Product Partners LP
NASDAQ:CPLP
Balance Sheet
Balance Sheet Decomposition
Capital Product Partners LP
Capital Product Partners LP
Balance Sheet
Capital Product Partners LP
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
164
|
90
|
107
|
63
|
21
|
58
|
47
|
20
|
145
|
192
|
|
| Cash Equivalents |
164
|
90
|
107
|
63
|
21
|
58
|
47
|
20
|
145
|
192
|
|
| Total Receivables |
3
|
3
|
3
|
5
|
16
|
4
|
4
|
8
|
7
|
4
|
|
| Accounts Receivables |
3
|
3
|
3
|
5
|
16
|
3
|
3
|
6
|
6
|
4
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
|
| Inventory |
3
|
4
|
5
|
5
|
2
|
2
|
4
|
5
|
7
|
6
|
|
| Other Current Assets |
2
|
3
|
4
|
32
|
26
|
3
|
3
|
5
|
8
|
23
|
|
| Total Current Assets |
172
|
100
|
118
|
106
|
65
|
66
|
58
|
38
|
166
|
226
|
|
| PP&E Net |
1 187
|
1 334
|
1 368
|
1 265
|
586
|
577
|
712
|
1 782
|
1 782
|
2 807
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
586
|
577
|
712
|
1 782
|
1 782
|
2 807
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
143
|
172
|
211
|
218
|
222
|
266
|
|
| Other Long-Term Assets |
131
|
122
|
113
|
96
|
735
|
61
|
52
|
66
|
49
|
108
|
|
| Total Assets |
1 490
N/A
|
1 556
+4%
|
1 599
+3%
|
1 466
-8%
|
1 385
-6%
|
704
-49%
|
822
+17%
|
1 885
+129%
|
1 997
+6%
|
3 140
+57%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
5
|
8
|
9
|
10
|
14
|
13
|
9
|
10
|
8
|
14
|
|
| Accrued Liabilities |
6
|
8
|
8
|
15
|
17
|
16
|
11
|
11
|
18
|
29
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
5
|
12
|
40
|
51
|
38
|
27
|
36
|
98
|
73
|
103
|
|
| Other Current Liabilities |
29
|
33
|
36
|
48
|
47
|
9
|
6
|
12
|
20
|
38
|
|
| Total Current Liabilities |
45
|
61
|
92
|
123
|
115
|
65
|
62
|
131
|
119
|
184
|
|
| Long-Term Debt |
570
|
556
|
563
|
404
|
254
|
232
|
339
|
1 211
|
1 216
|
1 672
|
|
| Other Liabilities |
3
|
1
|
16
|
6
|
135
|
0
|
0
|
18
|
24
|
109
|
|
| Total Liabilities |
617
N/A
|
618
+0%
|
671
+9%
|
533
-21%
|
504
-5%
|
297
-41%
|
400
+35%
|
1 360
+240%
|
1 358
0%
|
1 965
+45%
|
|
| Equity | |||||||||||
| Common Stock |
873
|
938
|
928
|
933
|
881
|
407
|
422
|
530
|
647
|
1 184
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
4
|
8
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
2
|
|
| Total Equity |
873
N/A
|
938
+7%
|
928
-1%
|
933
+1%
|
881
-6%
|
407
-54%
|
422
+4%
|
526
+24%
|
638
+21%
|
1 175
+84%
|
|
| Total Liabilities & Equity |
1 490
N/A
|
1 556
+4%
|
1 599
+3%
|
1 466
-8%
|
1 385
-6%
|
704
-49%
|
822
+17%
|
1 885
+129%
|
1 997
+6%
|
3 140
+57%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
15
|
17
|
17
|
18
|
18
|
18
|
19
|
19
|
20
|
55
|
|
| Preferred Shares Outstanding |
14
|
13
|
13
|
13
|
13
|
0
|
0
|
0
|
0
|
0
|
|